LGD-4033 (Ligandrol) Research Solution in Canada
This listing supplies LGD-4033 (Ligandrol) as a labelled liquid research solution for laboratory identification, analytical comparison, and controlled research workflows. It is not a dietary supplement, medication, or product for human or veterinary use.
Product specifications
| Compound | LGD-4033 (Ligandrol) |
|---|---|
| Classification | selective androgen receptor modulator (SARM) |
| Listed concentration | 10 mg/mL |
| Volume | 30 mL |
| Total listed compound | 300 mg |
| Format | Labelled liquid research solution |
| Purity specification | ≥98% |
| Documentation | Material-batch documentation status available from support |
Compound identity and classification
LGD-4033 (Ligandrol) is classified as a selective androgen receptor modulator (SARM). Correct classification matters when comparing research catalogues: related compounds can appear beside SARMs without sharing the same primary target or mechanism.
LGD-4033 has published human pharmacokinetic data from a randomized, placebo-controlled 21-day study involving 76 healthy men. The study measured pharmacokinetics and multiple biomarkers and reported dose-related changes in several hormone and lipid measures. A short exploratory trial does not establish long-term safety or product approval.
Published findings should be read as study-specific observations, not as proof of efficacy, safety, or a recommendation for use outside an authorized research setting.
Understanding the listed concentration
The listed concentration of 10 mg/mL describes the product format. In a 30 mL bottle, this corresponds to 300 mg of listed compound in total. Concentration information supports inventory control and analytical planning; it is not dosage, cycle, or administration guidance.
Testing documentation and material-lot COAs
Third-party HPLC documentation is maintained for the applicable incoming compound material lot, with a listed purity standard of ≥98%. COA documentation relates to the applicable incoming material batch; its reference is not expected to match a separate number on an individual finished bottle.
To request available documentation, email [email protected] with the product name or order number. See our Testing & COA Documentation page for help interpreting identity, purity, method, and material-lot information.
Research-use boundaries and handling
This product is sold strictly for laboratory and research purposes. It is not intended for human consumption, therapeutic use, bodybuilding use, athletic performance use, veterinary use, or the diagnosis, treatment, cure, or prevention of disease.
Keep the container sealed and follow the storage information on its label or accompanying documentation. Record the product name, concentration, receipt date, and applicable documentation in laboratory inventory records. Contact support for product-specific documentation or handling questions.
Frequently asked questions
What does this bottle contain?
It contains one labelled 30 mL liquid research solution of LGD-4033 (Ligandrol) at a listed concentration of 10 mg/mL, representing 300 mg of listed compound in total.
Is LGD-4033 a SARM?
LGD-4033 (Ligandrol) is a selective androgen receptor modulator (SARM). This classification is provided for catalogue accuracy and should not be interpreted as a safety or efficacy claim.
Can I request a COA?
Yes, where applicable. COA documentation relates to the applicable incoming material batch. Availability varies by compound; contact support to confirm what is currently available.
Does this page provide dosage or cycle guidance?
No. Concentration describes the supplied research format only. Canada SARMs does not provide dosage, cycle, administration, bodybuilding, or medical guidance.
Where can I compare research documentation?
Review the Research Library, the Complete SARMs Guide, and the FAQ.
Reviews
There are no reviews yet.